Agios Pharmaceuticals Announced It Will Present New Data And Results From Its Phase 3 Study On AG-946 At The 66th American Society Of Hematology Annual Meeting In San Diego, California From December 7-10, 2024
Agios Pharmaceuticals Announced It Will Present New Data And Results From Its Phase 3 Study On AG-946 At The 66th American Society Of Hematology Annual Meeting In San Diego, California From December 7-10, 2024
agios pharmaceuticals宣佈將於2024年12月7日至10日在加利福尼亞聖迭戈舉行的第66屆美國血液學會年會上,展示其AG-946第3期研究的新數據和結果。
Agios Pharmaceuticals Announced It Will Present New Data And Results From Its Phase 3 Study On AG-946 At The 66th American Society Of Hematology Annual Meeting In San Diego, California From December 7-10, 2024
agios pharmaceuticals宣佈將在2024年12月7日至10日於美國加利福尼亞州聖地亞哥舉行的第66屆美國血液學會年會上,發佈其AG-946階段3研究的新數據和結果。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。